Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.4 USD | -0.58% | -0.41% | +17.20% |
01:58pm | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
06/05 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.20% | 6.77B | |
+29.66% | 48.16B | |
-0.29% | 41.73B | |
+42.95% | 41.03B | |
-5.31% | 28.77B | |
+10.87% | 25.59B | |
-21.98% | 18.96B | |
+9.01% | 12.92B | |
+28.60% | 12.03B | |
-2.86% | 11.77B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Wedbush Raises Blueprint Medicines' Price Target to $80 From $75 After Higher-Than-Expected Q3 Financial Results, Keeps Outperform Rating